Skip to content
DataLookout
Menu

Taiho Oncology, Inc. clinical trial pipeline

Get alerts when Taiho Oncology, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: REZILIENT3 · (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) Trial sites reduced: 130 → 110 locations Taiho Oncology, Inc.Phase 3 NCT05973773
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
3
Phase 1/2
2
Phase 2
4
Phase 2/3
2
Phase 3
2

Disease areas by active trials, top 10 of 15

Get alerts when Taiho Oncology, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free